. I-SceI-induced DSB system. (A) To establish an inducible DSB system, a knock-in strategy was used for the insertion of an I-SceI site and neo gene (~1.2 kb) in the X chromosome. Genomic DNA was digested by SpeI and I-SceI. Probe l and Probe 2 were designed and used for Southern blotting to validate a single insertion. Parental HCT116 was used as a control. (B) Western blotting and immunostaining were performed to validate the inducible expression of I-SceI. (C) Following Dox and TA treatment, genomic DNA was extracted and digested by SpeI. Southern blotting was performed using Probe 2, and was repeated for three times. The abundance of bands was quantified mean ± SD.
Supplemental
. Removal of histones at the DSB in G1 and S phase cells. (A) The cells were synchronized at the G1/S boundary by double thymidine block, and then released into S phase for 4 hours. (B) ChIP assays were then performed to analyze the histone removal at the indicated time points. Antibodies against histone H2B and H4 were used for the ChIP assay. Data were shown as mean ± SD. Figure S4 . DNA repair factors do not affect histone removal at the DSB. (A) The cells were treated with Lig4 siRNA, BRCA2 siRNA or MRE11 inhibitor Mirin (50 μM). GFP reporter assays were used for examining NHEJ and HR respectively. (B) ChIP assays were then performed to analyze the histone removal at the indicated time points. Figure S5 . The impacts of PARP inhibition, phosphorylation or ubiquitination on histone removal at I-SceI induced DSB. Cells were treated with 1 μM olaparib for 2 hours or transfected with PARP1 siRNA for 40 hours to inhibit PARP1 activity. Following DSB induction, the histone removal was examined by ChIP assays using antibodies against histone H2A, H2B and H4. Primers 1 and 5 were used for the qPCR assays. The ATM inhibitor KU60019, ATR inhibitor VE822, DNA-PK inhibitor NU7441 and RNF8 siRNA were used to inhibit the activities of ATM, ATR, DNA-PK or RNF8, respectively. Relative enrichment was shown as mean ± SD.

Supplemental Figure S6 . The impacts of PARG on histone removal at I-SceI induced DSB. Following DSB induction in cells overexpressing PARG, the histone removal was examined by ChIP assays using antibodies against histone H2A, H2B and H4. Primers 1 and 5 were used for the qPCR assays. Relative enrichment was shown as mean ± SD.
Supplemental Figure S7 . Analysis of histones modifications at I-Sce1-induced DSB. Following I-Sce1-GR induction, ChIP assays were performed with anti-pan-H2A acetylation, anti-pan-H2B acetylation, anti-H3K9 acetylation, anti-H3K14 acetylation, anti-H4K16 acetylation, anti-H3K9 dimethylation, anti-H3K36 dimethylation, anti-H3K79 dimethylation, anti-H4K20 dimethylation, anti-H3K27 trimethylation and anti-H4K20 trimethylation antibodies. The results were normalized with anti-H2A, H2B, H3 or H4 antibodies. qPCR assays were performed with Primers 1 and 5 (shown as P1 and P5 in Figure 2A and Supplemental  Table 1 ) . The results are shown as mean ± SD. Figure S8 . PARP1, RNF8 or histone chaperons were knocked down in HCT116 cells with the I-SceI inducible system. The efficiency of siRNA knock-down was analyzed by Western blotting with indicated antibodies. Actin was used as a control for protein loading.
Supplemental Figure S9 . The impact of SSRP1, SPT16, ASF1A and CAF1 on histone removal. (A) Cells were transfected with siRNA targeting SPT16, ASF1A or CAF1 for two days before the DSB was induced. Cells were then subjected to ChIP assay using primer set 1. Antibodies against histone H2B, and H3 were used for the ChIP assay. The results were presented as mean ± SD. (B) Cells were transfected with SSRP1 siRNA and/or PARP1 siRNA. DSB was induced and ChIP assays were performed using primer set 1. Data were shown as mean ± SD. Figure S10. (A) The recruitment of histone chaperones were detected by ChIP assay using I-SceI-induced DSB system. After the DSB induction, cells were subjected to ChIP assay using primer 1 and primer 5. Antibodies against ANP32E, ASF1B, HIRA, sNASP, DAXX, ANP32B and Rbap46 were used in the ChIP assay. The results were shown as mean ± SD. (B) The cells were treated with ANP32E siRNA or DAXX siRNA. Histone removal was examined using ChIP assays.
Supplemental Figure S11 . The PARylation mediates the recruitment of SSRP1 to the DSB. Cells were treated with 1 μM olaparib for 2 hours followed the DSB induction. Cells were then subjected to ChIP assay for detecting the recruitment of SSRP1. Primer 1 and primer 5 were used in this assay. The results were shown as mean ± SD. Figure S12 . SSRP1 mediates the recruitment of the FACT complex to DNA lesions. (A) Left panel: FLAG-SSRP1 was co-expressed with HA-SPT16 or HA-SPT16DD mutant in U2OS cells. Co-IP assay was performed with indicated antibodies. Right panel: FLAG-SSRP1 or FLAG-SSRP1DD was co-expressed with HA-SPT16 in U2OS. Reciprocal co-IP was performed to validate the role of the DD domain in the interaction. (B) Endogenous SSRP1 was knocked down by siRNA in U2OS cells. The cells were reconstituted with full length SSRP1 or the SSRP1DD mutant. The expression of SSRP1 was examined by Western blot (upper panel). Laser microirradation assay was performed to examine the recruitment of GFP-SPT16 in these cells (lower panel). Results were shown as mean ± SD.
